OKUR — OnKure Therapeutics, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1637715 ·
Last close
$2.58
Market Cap
$104.50M
52W High
$5.38
52W Low
$2.01
ADV30
393,459
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -19,351,000 -17,846,000 167,077,000 151,443,000 9,340,000
Jun 2026 0 — -16,899,000 -15,346,000 179,353,000 166,502,000 7,245,000
Mar 2026 0 — -15,615,000 -15,157,000 198,694,000 192,106,000 14,341,000
Dec 2025 0 — -14,125,000 -13,503,000 62,117,000 59,050,000 5,933,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-47,886,000
Investing CF
$-11,853,000
Financing CF
$140,851,000
CapEx
$-49,000
Dividends Paid
—
Buybacks
$-8,000
EPS Diluted TTM
$-2.77
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-262,590,000
Inventory
—
Receivables
—
ST Investments
$11,862,000
EBIT TTM
$-63,857,000
Pretax Income TTM
$-61,852,000
Interest Exp TTM
$8,000
Analysts
4

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -62,950,000 -59,517,000 62,117,000 5,933,000 56,184,000 -51,828,000
Dec 2024 0 -54,386,000 -52,673,000 114,907,000 11,079,000 103,828,000 -51,117,000
Dec 2023 0 -36,934,000 -35,311,000 35,734,000 137,576,000 -101,842,000 -34,546,000
Dec 2022 0 -29,766,000 -29,512,000 15,999,000 70,417,000 -54,418,000 -26,953,000

TTM Snapshot

Revenues TTM
$0
NetIncome TTM
$-58,705,000
OpCashFlow TTM
—
Assets (Latest)
$179,353,000
Forward EPS
$-1.53

Max Pain — expiry 2027-02-19 (volume-derived — Yahoo OI feed degraded)

max pain strike: $2.50 · spot: $2.82 · call volume: 10 · put volume: 1

Peers — same industry

TickerNameMarket CapLastDaily %
CATX Perspective Therapeutics, Inc. $103.84M $0.86 —
ORGO Organogenesis Holdings Inc. $105.35M $0.81 —
NERV Minerva Neurosciences, Inc. $103.13M $2.16 —
NRXP NRX Pharmaceuticals, Inc. $106.07M $2.45 —
OGI ORGANIGRAM GLOBAL INC. $101.90M $0.71 —

News headlines (Yahoo Finance, 1h cache)

OnKure Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Highlights
2026-11-04 21:05 · Yahoo
OnKure Therapeutics to Participate in the Morgan Stanley Global Healthcare Conference
2026-08-31 12:00 · Yahoo
OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
2026-08-04 20:05 · Yahoo
OnKure Therapeutics Spotlights Allosteric PI3Kα Drugs as 2027 IND Targets Near
2026-07-15 17:02 · Yahoo
OnKure Therapeutics to Host Virtual KOL Event to Discuss PI3Kα Inhibitor Medicines: Selectivity Matters & Pan-Mutant Allosteric Inhibition Delivers, on July 15, 2026
2026-07-02 12:00 · Yahoo
OnKure Therapeutics Reports First Quarter 2026 Financial Results
2026-05-05 20:05 · Yahoo
TMO Q1 Earnings Preview: Will Life Sciences Solutions Lead Results?
2026-04-16 13:18 · Yahoo
OnKure Therapeutics Announces Oversubscribed $150 Million Private Placement to Advance Next-Generation PI3Kα Pan-Mutant Selective Inhibitor Candidates in Breast Cancer and Vascular Anomalies
2026-03-27 12:00 · Yahoo
OnKure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
2026-03-12 20:05 · Yahoo
Promising Penny Stocks To Watch In December 2025
2025-12-09 18:05 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.